The Oncologist Online -- Table of Contents Volume 9, Supplement 3 , 2004

Volume 9, Supplement 3 , 2004 [Index by author]

The Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors

Find articles in this issue containing these words:
[Search ALL Issues]

Receive this page by email each issue: [Sign up for eTOCs]

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

The Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors: Dennis J. Slamon
The Oncologist 2004; 9(Supplement 3 ): 1-3; doi:10.1634/theoncologist.9-suppl_3-1
[Full Text] [PDF]

Monoclonal Antibodies, Small Molecules, and Vaccines in the Treatment of Breast Cancer: Francisco J. Esteva
The Oncologist 2004; 9(Supplement 3 ): 4-9; doi:10.1634/theoncologist.9-suppl_3-4
[Abstract] [Full Text] [PDF]

Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib: Howard A. Burris, III
The Oncologist 2004; 9(Supplement 3 ): 10-15; doi:10.1634/theoncologist.9-suppl_3-10
[Abstract] [Full Text] [PDF]

The Role of ErbB Inhibitors in Trastuzumab Resistance: Kathy D. Miller
The Oncologist 2004; 9(Supplement 3 ): 16-19; doi:10.1634/theoncologist.9-suppl_3-16
[Abstract] [Full Text] [PDF]

Overcoming Endocrine Therapy Resistance by Signal Transduction Inhibition: Matthew Ellis
The Oncologist 2004; 9(Supplement 3 ): 20-26; doi:10.1634/theoncologist.9-suppl_3-20
[Abstract] [Full Text] [PDF]

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

Cover Illustration:

Cover

Oriental Poppy by Bernique Longley.

Laudanum, or tincture of opium, was for many decades the only "treatment" for cancer in the Old West; the Oriental Poppy has, therefore, been chosen as the journal's icon.

HOME

HELP

SUBSCRIPTIONS